tiprankstipranks
Keros Therapeutics, Inc. (KROS)
NASDAQ:KROS
US Market
KROS
Keros Therapeutics
RESEARCH TOOLSreports
Want to see KROS full AI Analyst Report?

Keros Therapeutics (KROS) Revenue

365 Followers
StatisticsMarket CapRevenue

Keros Therapeutics Revenue

Keros Therapeutics had a revenue of 367.00K in the quarter ending Mar 31, 2026, with -4.68%. This bring the company's revenue in the last twelve months to 33.18M, Increased -86.40%. In the fiscal year ending Dec 31, 2025, Keros Therapeutics had annual revenue of 244.06M with 6774.96% growth.
Revenue (ttm)
33.18M
Revenue Growth
-84.55%
P/S Ratio
0.89
Revenue/Employee
$1,497,307
Employees
163
Market Cap
$217.31M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
244.06M240.51M+6,774.96%
Dec 31, 2024
3.55M3.40M+2,250.99%
Dec 31, 2023
151.00K―+∞%
Dec 31, 2022
―-20.10M-100.00%
Dec 31, 2021
20.10M―+∞%
Dec 31, 2020
―-10.00M-100.00%
Dec 31, 2019
10.00M0.00―
Dec 31, 2018
10.00M――